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Abstract  18 
Objective To compare the effect of two different intra-operative end-tidal carbon 19 
dioxide tensions on apnoeic duration in the recovery period in horses.  20 
Study Design Prospective randomised clinical study. 21 
Animals Eighteen healthy client-owned adult horses (ASA I-II) admitted for elective 22 
surgery. Horses were of median body mass 595 (238-706) kg and mean age 9 ± 5 years.  23 
Methods A standardised anaesthetic protocol was used. Horses were positioned in 24 
dorsal recumbency and randomly allocated to one of two groups. Controlled mechanical 25 
ventilation (CMV) was adjusted to maintain end tidal carbon dioxide tension (PE´CO2) 26 
at 40 ± 5 mmHg (5.3 ± 0.7 kPa) (group40) or 60 ± 5 mmHg (8.0 ± 0.7 kPa) (group60). 27 
Arterial blood gas analysis was performed at the start of the anaesthetic period (T0), at 28 
one point during the anaesthetic (T1), immediately prior to disconnection from the 29 
breathing system (T2) and at the first spontaneous breath in the recovery box (T3).The 30 
time from disconnection from the breathing system to return of spontaneous ventilation 31 
(RSV) was recorded. Data were analysed using a two sample t-test or Mann-Whitney U 32 
test and significance assigned when p < 0.05.  33 
Results Horses in group60 resumed spontaneous breathing significantly earlier than 34 
those in group40, (52 (14-151) and 210 (103-542) seconds respectively) (p < 0.001). 35 
Arterial oxygen tension (PaO2), pH, base excess (BE) and plasma bicarbonate (HCO3
-) 36 
were not different between the groups at RSV, however PaO2 was significantly lower in 37 
group60 during (T0, T1) and at the end of anaesthesia (T2).   38 
Conclusions and clinical relevance Aiming to maintain intra-operative PE´CO2 at 60 ± 39 
5 mmHg (8.0 ± 0.7 kPa) in mechanically ventilated horses resulted in more rapid RSV 40 
compared to when PE´CO2 was maintained at 40 ± 5mmHg (5.3 ± 0.7 kPa).  41 
Keywords: horse, mechanical ventilation, recovery from anaesthesia, hypercapnia. 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
Introduction 67 
In anaesthetised horses, the dose-dependent respiratory depression produced by 68 
isoflurane (Steffey et al. 1987) and effect of recumbency may necessitate controlled 69 
mechanical ventilation (CMV) to improve pulmonary function (Day et al. 1995). 70 
Cessation of CMV may result in an apnoeic period of variable duration before 71 
spontaneous ventilation resumes (Wright & Hildebrand 2001). The impact of this 72 
apnoeic period and strategies to facilitate the transition from mechanical to spontaneous 73 
ventilation have been investigated (Wright & Hildebrand 2001; Brosnan et al. 2012; Ida 74 
et al. 2013). Horses may be ‘weaned-off’ mechanical ventilation to ensure return to 75 
spontaneous ventilation (RSV) prior to transfer to recovery by reducing minute 76 
ventilation towards the end of surgery.  77 
In comparison to abrupt discontinuation of CMV however, this weaning process may 78 
result in a greater incidence of horses moving on the hoist during transfer to the 79 
recovery box (Wright & Hildebrand 2001). Weaning has been associated with 80 
hypoxaemia even with the use of oxygen-rich inspired gas (Wright & Hildebrand 2001; 81 
Santos et al. 2003). Apnoeic horses may remain normoxaemic due to apnoeic mass 82 
movement oxygenation (AMMO) (Wright & Hildebrand 2001) but the effect of 83 
prolonged apnoea on this mechanism is not known.  84 
Isoflurane elimination during recovery may also be affected by hypoventilation since 85 
the partial pressure of volatile anaesthetic agent in the alveolar gas decreases as a 86 
function of alveolar ventilation (Eger 1974). It has been demonstrated that insufflation 87 
of 5-10% carbon dioxide (CO2) in oxygen (O2) in the immediate recovery period 88 
increases alveolar ventilation by inducing hypercapnic hyperpnoea, resulting in faster 89 
times to standing without affecting recovery quality (Brosnan et al. 2012). Normocapnia 90 
has been defined as arterial carbon dioxide tension (PaCO2) 40mmHg (5.33 kPa) 91 
(Wagner 1993) and mechanical ventilation should aim to maintain PaCO2 between 35 92 
and 50 mmHg (4.67- 6.67 kPa) (Hartsfield 2007). However, considering the detrimental 93 
effects of CMV on cardiac output (Hodgson et al. 1986; Steffey et al. 1992; Mizuno et 94 
al. 1994), there may be cardiovascular benefits of mild hypoventilation, with some 95 
studies advocating maintaining PaCO2 between 50-70 mmHg (6.67-9.33 kPa) (Kerr & 96 
McDonell 2009) or below 70-75 mmHg (9.33-10 kPa) (Taylor &Young 1993; Blissitt et 97 
al. 2008). Permitting mild to moderate hypercapnia may also facilitate the transition 98 
from CMV to spontaneous breathing. This study was designed to investigate the effect 99 
of two different intra-operative end-tidal carbon dioxide tension (PE´CO2) values on the 100 
duration of apnoea in the immediate recovery period. We hypothesised that maintaining 101 
intra-operative PE´CO2 values at 60 ± 5mmHg (8.0 ± 0.7 kPa) (group60) would result in 102 
a faster RSV compared to maintaining PE´CO2 values at 40 ± 5 mmHg (5.3 ± 0.7 kPa).  103 
Materials and Methods  104 
Study Design 105 
Prospective, randomised, controlled clinical study approved by the University of 106 
Liverpool Ethics Committee (VREC94). Systemically healthy (ASAI-II) adult horses 107 
(>3 years of age) presenting to The Philip Leverhulme Equine Hospital for elective 108 
orthopaedic or soft tissue surgery were eligible for inclusion if they were to be 109 
positioned in dorsal recumbency, showed no evidence of respiratory disease based on 110 
physical examination and informed owner consent was granted.   111 
Anaesthetic Protocol  112 
Food but not water was withheld for at least eight hours prior to induction of general 113 
anaesthesia. Pre-anaesthetic medication consisted of acepromazine maleate 0.03 mg kg-1 114 
intramuscularly (IM) (Vetranquil; Ceva, France) 45 minutes prior to aseptic placement 115 
of a 12 Gauge intravenous cannula (Intraflo 2; Vygon, France). Romifidine 50-80 µg 116 
kg-1 intravenously (IV) (Sedivet; Boehringer Ingelheim, UK) and morphine 0.2mg kg -1 117 
IV (Morphine Sulphate; Wockhardt, UK) were administered within 15 minutes of 118 
intravenous cannula placement. Induction of general anaesthesia using ketamine 2.2 mg 119 
kg-1 IV (Ketaset; Pfizer, UK) and diazepam 0.05 mg kg-1 IV (Diazepam; Hameln 120 
Pharmaceuticals, UK) was followed by orotracheal intubation. General anaesthesia was 121 
maintained using isoflurane (Isoflo; Abbott, UK) in 100% oxygen delivered via a large 122 
animal circle breathing system (LAVC 2000; Eickemeyer, Germany). The circle system 123 
was not prefilled with oxygen and isoflurane. Fresh gas flow was 10 L min-1 for the first 124 
5 minutes, reduced to 10 mL kg-1 for the anaesthesia duration.  Mechanical ventilation 125 
was delivered via pressure-limited flow-controlled ventilator (Mark 7 Bird Servo; 126 
Medical Dist Co Inc., USA) and adjusted to maintain PE´CO2 at either 40 ± 5 mmHg 127 
(5.3 ± 0.7 kPa) (group40) or 60 ± 5 mmHg (8.0 ± 0.7 kPa) (group60). Both tidal volume 128 
and respiratory rate adjustments were carried out in a step wise manner to adjust minute 129 
ventilation and achieve the target PE´CO2. A 20 Gauge (Intraflon; Vygon, France) 130 
cannula was placed in the mandibular artery to permit invasive arterial blood pressure 131 
measurement and acquisition of samples for blood gas analysis. Arterial blood gas 132 
analysis was performed using two blood gas analysers (Radiometer ABL77; Radiometer 133 
Medical, Denmark, RapidPoint 500; Siemens, UK) for which statistical agreement was 134 
confirmed prior to utilisation of data. Other instrumentation included 135 
electrocardiography, pulse oximetry, respiratory gases and volatile anaesthetic agent 136 
monitoring (Datex-Ohmeda S/5; GE Healthcare, UK). Intravenous fluids (Vetivex 11; 137 
Dechra, UK) were administered (3-4 mL kg-1 hr-1) throughout the duration of general 138 
anaesthesia. Dobutamine (Dobutamine; Wockhardt, UK) was administered 139 
intravenously as required to ensure mean arterial pressure remained above 70 mmHg.  140 
Sample collection  141 
Arterial blood gas analysis was performed on four occasions for each horse. The first 142 
sample (T0) was withdrawn immediately after an arterial cannula was secured. A 143 
second sample (T1) was taken approximately 20-30 minutes later to ensure that 144 
ventilator settings were appropriate and to assess the difference between PaCO2 and 145 
PE´CO2.  A third sample (T2) was withdrawn at the end of anaesthesia immediately 146 
prior to disconnection from the breathing system and the final sample was drawn at the 147 
moment spontaneous breathing resumed in the recovery box whilst the orotracheal tube 148 
was still in place (T3). Samples were drawn over three consecutive breaths for T0, T1 149 
and T2. Sampling at T3 was drawn at the moment of RSV via an arterial cannula which 150 
was then either immediately removed or secured for recovery and removed when the 151 
horse was standing. All samples were analysed immediately after collection but 152 
temperature correction was not performed. The time from breathing system 153 
disconnection to RSV was recorded. After sampling was completed at RSV, oxygen 154 
was supplemented via a demand valve and nasal insufflation. 155 
Pilot study and sample size calculations 156 
Sample size calculations were based on a pilot study involving ten horses randomly 157 
allocated to two groups. Pilot data demonstrated RSV in group60 of 68 ± 50 seconds 158 
compared to 327 ± 176 seconds in group40. A 50% reduction in apnoeic time was 159 
considered clinically important and in order to demonstrate statistical differences in 160 
time to RSV between the two groups (alpha error 0.05, beta error 0.15), it was estimated 161 
that nine horses would be required in each group (Eng, 2003).  162 
Animals The study population included 18 horses comprising a mixed population of 163 
males and females (11 geldings, 3 mares and 4 stallions) of median body mass 595 164 
(238-706) kg and mean age 9 ± 5 years. 165 
Statistical Analysis  166 
All continuous study data were assessed for normal distribution using the Anderson-167 
Darling test. Parametric data is displayed as mean ± standard deviation and analysed 168 
using a two-sample Student’s t-test. Non-parametric data is displayed as median (range) 169 
and analysed using the Mann-Whitney U test. Computer software (Minitab 17 170 
Statistical Software; Minitab Ltd, UK) was used to analyse the data and statistical 171 
significance was assigned when p < 0.05. No statistical differences in parameters and 172 
baseline data were found between pilot and study data for each group so the data was 173 
pooled.  174 
Results  175 
Eighteen horses completed the study and no adverse events were recorded. There was 176 
no difference between the groups in body mass, age, anaesthetic duration, time to 177 
standing, end-tidal isoflurane concentration or rate of dobutamine infused over the 178 
anaesthetic period (Table 1). Loco-regional analgesia techniques were carried out where 179 
applicable to the surgical procedure undertaken and non-steroidal anti-inflammatory 180 
drugs were administered to all horses (Table 2).  181 
Time to RSV was significantly shorter in group60, with a median time of 52 (14-151) 182 
seconds compared to 210 (103-542) seconds in group40 (p < 0.001) (Figure 1).  183 
At the end of anaesthesia (T2), pH was significantly lower in group 60 but at the time of 184 
RSV (T3) there was no difference in pH between groups (Table 3). At RSV, there was 185 
no difference between the groups in PE´CO2 or PaCO2 (Table 3). Using data pooled 186 
from both groups, the overall mean PaCO2 at RSV was 66 ± 11 mmHg (8.8 ± 1.4 kPa). 187 
The PaCO2- PE´CO2 difference at the end of anaesthesia (T2) was significantly lower in 188 
group40 but there was no difference between groups at RSV (T3) (Table 3). Arterial 189 
oxygen tension (PaO2) was significantly lower in group60 during (T1) at the end of 190 
anaesthesia (T2) but at the time of RSV (T3) there was no difference between the 191 
groups (Table 3). At RSV, PaO2 was less than 60 mmHg (8.0 kPa) in three horses in 192 
each group. Base Excess (BE) and plasma bicarbonate (HCO3
-) concentrations were not 193 
different between the groups at any time point (Table 3).  194 
During anaesthesia, two horses in group60 took occasional spontaneous breaths 195 
resulting in slightly lower than target PE´CO2 values while one horse breathed 196 
spontaneously throughout general anaesthesia leading to exclusion from the study (Fig 197 
2). One horse in group40 was severely hypotensive soon after the onset of general 198 
anaesthesia leading to the withdrawal of CMV and the exclusion of the horse from the 199 
study (Fig 2). Data for PE´CO2 at RSV was lost for two horses in group60 and one horse 200 
in group40 due to equipment failure but the study remained adequately powered for the 201 
primary objective. 202 
Discussion  203 
Our results show that maintaining intra-operative PE´CO2  at 60 ± 5 mmHg (8.0 ± 0.7 204 
kPa) shortens the time to RSV compared to maintaining intra-operative PE´CO2 at 40 ± 205 
5 mmHg (5.3 ± 0.7 kPa). During volatile agent anaesthesia, the ventilatory response to 206 
PaCO2 is reduced in a dose dependent manner compared to the conscious state (Lumb 207 
2010a). This was reflected in the current study by the elevated overall PaCO2 in both 208 
groups at RSV and is consistent with a previous study where PaCO2 was 66 ± 9 mmHg 209 
(8.8 ± 1.2 kPa) at the time spontaneous breathing resumed after cessation of CMV in 210 
isoflurane-anaesthetised horses (Wright & Hildebrand 2001). Since PaCO2 was 211 
significantly higher in group60 at the end of anaesthesia, apnoeic threshold was reached 212 
faster resulting in an earlier onset of spontaneous breathing. During a period of apnoea 213 
after CMV in halothane-anaesthetised horses, the rate of rise in PaCO2 in horses is 214 
reported to be 12 mmHg (1.6 kPa) in the first minute and 6 mmHg (0.8 kPa) in 215 
subsequent minutes (Hubbell & Muir 1985). In comparison to this finding, horses in our 216 
study in group40 demonstrated a slightly slower mean rate of rise in PaCO2 which is in 217 
agreement with previous reports in isoflurane-anaesthetised horses (Wright & 218 
Hildebrand 2001).  219 
Aiming to maintain PE´CO2 at 60 ± 5 mmHg (8.0 ± 0.7 kPa) may influence delivered 220 
minute volume and in our study, delivered minute volume was significantly lower in 221 
group60 which may have contributed to lower PaO2 values seen during general 222 
anaesthesia. Although these values did not approach hypoxaemia, this finding should be 223 
considered when managing clinical cases.  224 
Hypoxaemia may also influence ventilatory response and potential sources of 225 
hypoxaemia in the recovery period include decreased alveolar ventilation, diffusion 226 
impairment, increased shunt fraction and ventilation-perfusion mismatching (Richards 227 
1982; Lumb 2010b). In conscious standing horses, hypoxaemic ventilatory drive occurs 228 
when PaO2 reaches 38 mmHg (5.1 kPa) (Pelletier & Leith 1995). In our study, at the 229 
end of anaesthesia, PaO2 values in group60 were significantly lower than in group40 230 
and whilst hypoxic drive cannot be ruled out as a contributory factor in RSV there was 231 
no difference in PaO2 between groups at RSV. These findings are in agreement with a 232 
previous study which showed that there was no advantage in terms of PaO2 in horses 233 
which were weaned from ventilation compared to those which demonstrated apnoea 234 
after disconnection from CMV (Wright & Hildebrand 2001). In our study, nasal 235 
insufflation of oxygen (15L/min) and an oxygen demand valve were utilised after RSV 236 
which have been shown to improve arterial oxygenation (Waterman et al. 1982; Mason 237 
et al. 1987).   238 
The negative impact of CMV on the equine cardiovascular system has been documented 239 
(Hodgson et al. 1986; Steffey et al. 1992; Mizuno et al. 1994). In circumstances where 240 
CMV is necessary, mild hypoventilation (reduced minute ventilation with associated 241 
increase in PaCO2 (Hubbell & Muir 2014)), may have beneficial cardiovascular effects. 242 
In halothane-anaesthetised horses, a reduction in ventilation frequency during CMV 243 
resulted in increased PaCO2 which stimulated spontaneous breathing. This was 244 
associated with an improvement in cardiac output (Nyman & Hedenstierna 1988). In 245 
our study, although cardiovascular function was not investigated, there was no 246 
difference in dobutamine infusion rates between groups intra-operatively.  247 
Faster recovery times have followed a shorter apnoeic phase in recovery after weaning 248 
from ventilation compared to horses which were not weaned and demonstrated an 249 
apnoeic pause (Wright & Hildebrand 2001). However, in our study, time to standing 250 
was similar between groups and since recovery quality was not analysed, it is not 251 
known whether a shorter apnoeic phase influenced recovery quality. In the current 252 
study, no movement of horses occurred during hoisting to the recovery box which 253 
contrasts with an earlier study where horses weaned from ventilation moved during 254 
transport to the recovery box which is considered undesirable (Wright & Hildebrand 255 
2001).     256 
Limitations of the study relate to its clinical nature. Standardisation of the anaesthetic 257 
protocol was adhered to where possible but different surgical procedures necessitated 258 
varying analgesic techniques. The use of loco-regional analgesic techniques may have 259 
afforded a reduction in isoflurane requirement facilitating a shorter time to RSV, 260 
however there was no difference in end-tidal isoflurane requirements between groups. 261 
Adjustments made to tidal volume and respiratory rate to achieve the PE´CO2 target for 262 
each group were not standardised but were carried out in a stepwise manner and the 263 
resulting normal distribution of data in each group indicate that a fairly systematic 264 
approach was employed. During anaesthesia, two horses in group60 took occasional 265 
spontaneous breaths resulting in slightly lower than target PE´CO2 values. This may 266 
have been due to the effect of PaCO2 on ventilatory drive which may be dampened 267 
during general anaesthesia but remained present in group60 where higher PE´CO2 268 
values were aimed for. Furthermore, the study was not blinded which may allow a 269 
source of bias to be present.    270 
The results of our study show that maintaining intra-operative PE´CO2 at 60 ± 5mmHg 271 
(8.0 ± 0.7 kPa) results in a significantly shorter apnoeic phase in recovery compared to 272 
maintaining intra-operative PE´CO2  at 40 ± 5mmHg (5.3 ± 0.7 kPa). Although the 273 
apnoeic phase was shorter in group60, PaO2 values were lower in this group during and 274 
at the end of anaesthesia. However, at the time of RSV, PaO2 values were not different 275 
between groups. In conclusion, the two different intra-operative PE´CO2 values 276 
investigated in this study influenced the time to RSV, however, to gain further 277 
information pertaining to a wider range of PE´CO2 values and potential clinical 278 
advantages of a shorter apnoeic phase, further investigation is required.  279 
 280 
 281 
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  345 
Table . Data for 18 anaesthetised horses where mechanical ventilation was adjusted to 346 
maintain end-tidal carbon dioxide (PE´CO2) at 40 ± 5 mmHg (5.3 ± 0.7 kPa) (Group40) 347 
or 60 mmHg ± 5 mmHg (8 ± 0.7 kPa) (Group60).  348 
 349 
Group Anaesthetic 
duration 
(minutes) 
Time to 
standing 
(minutes) 
End-tidal 
isoflurane 
concentration 
(%) 
Tidal volume 
delivered (mL 
kg-1) 
Respiratory 
rate 
(breaths per 
minute) 
Dobutamine 
infusion rate  
(µg kg-1 min-
1) 
Group40 109 ± 42 
 
22 (16-60) 
 
1.1 ± 0.1 10.5 ± 2.0* 6 ± 1* 0.8 ± 0 .3 
Group60 87 ± 36 
 
23 (14-75) 
 
1.2 ± 0.1 8.4 ± 1.4* 5 ± 1* 1.0 ± 0.4 
p-value  0.26  0.9 0.14 0.02 0.03 0.51 
* Statistical difference between the groups (p < 0.05). Data is displayed as mean ± 350 
standard deviation (SD) or median (range). 351 
  352 
Table 2. Surgical procedures, loco-regional anaesthesia techniques and non-steroisal 353 
anti-inflammatory drug (NSAID) administration in 18 horses. For group details see 354 
Table 1. 355 
 Group40 Group60 
Surgical 
procedure 
Orthopaedic procedures 4 5 
Soft tissue procedures 
 
5 4 
Local 
technique  
Caudal epidural (Co1-Co2) morphine a 
(0.1mg kg-1) and methadoneb (0.1 mg kg-1) 
2 1 
Intra-testicular mepivacainec (100 mg total). 1 1 
Pudendal perineural levobupivacained 
(50mg). 
0 1 
Perineural anaesthesia of the medial and 
lateral palmar and palmar metacarpal nerves 
using levobupivacained (50mg). 
 
1 0 
NSAID Flunixine  1.1mg kg-1 IV 
 
5 3 
Phenylbutazonef  4.4mg kg-1 IV 4 6 
aMorphine Sulphate (Martindale Pharmaceuticals, UK), bPhyseptone (Martindale 356 
Pharmaceuticals, UK), cIntra-epicaine (Dechra, UK), d Chirocaine (Abbott, UK), e 357 
Meflosyl (Pfizer, UK), f Equipalazone (Dechra, UK). 358 
  359 
Table 3. Time to resume spontaneous ventilation (RSV) and arterial blood gas data for 360 
18 anaesthetised horses where mechanical ventilation was adjusted to maintain the end-361 
tidal carbon dioxide (PE´CO2) at 40 ± 5 mmHg (5.3 ± 0.7 kPa) (Group40) or 60 ± 5 362 
mmHg (8 ± 0.7 kPa) (Group60). 363 
 364 
Parameter  Group  T0 T1 T2 T3 
(RSV) 
Time to RSV 
(seconds)     
40 
60 
   210 (103-542)*  
52 (14-151) 
p<0.001 
pH    40 
60 
7.42 ± 0.03* 
7.33 ± 0.02 
p < 0.001 
7.41 ± 0.03* 
7.32 ± 0.03 
p < 0.001 
7.42 ± 0.02*  
7.31 ± 0.03 
p < 0.001 
7.33 ± 0.06  
7.35 ± 0.04   
p = 0.44 
PE´CO2 
(mmHg) 
40 
60 
40 (39-48)* 
52 (38-62) 
40 (40-42)* 
53 (44-63) 
40 (38-42)* 
54 (44-60) 
51 (42-62) 
44 (40-56) 
PE´CO2 
(kPa) 
40 
60 
5.3 (5.1-6.4) 
6.9 (5.1-8.3) 
p = 0.006) 
6.9 (5.1-8.3) 
7.1 (5.9-8.4) 
p < 0.001 
5.3 (5.1-5.6) 
7.2 (5.9-8) 
p <  0.001 
6.8 (5.6-8.3) 
5.9 (5.3-7.5) 
p = 0.2 
PaCO2 (mmHg) 
 
40 
60                     
49 ± 5* 
61 ± 11 
49 ± 4* 
66 ± 7 
53 ± 4*  
67 ± 8 
68 ± 13 
64 ± 9 
PaCO2 (kPa) 
 
40 
60 
6.5 ± 0.6 
8.2 ± 1.4 
p = 0.009 
6.5 ± 0.6 
8.8 ± 0.9 
p < 0.001 
7.1 ± 0.5 
8.9 ± 1 
p = 0.001 
9.1 ± 1.7 
8.6 ± 1.2 
p = 0.46 
PaCO2- PÉCO2 40 8 (2-12) 10 (1-14) 11 (6-15)* 16 (7-35) 
(mmHg) 60 12 (1-16) 13 (2-20) 18 (8-20) 17 (0-28) 
PaCO2- PÉCO2 
(kPa) 
40 
60 
1.1 (0.3-1.6) 
1.6 (0.1-2.1) 
p = 0.35 
1.3 (0.1-1.9) 
1.7 (0.3-2.7) 
p = 0.1 
1.5 (0.8-2) 
2.4 (1.1-2.7) 
p < 0.001 
2.1 (0.9-4.7) 
2.3 (0-3.7) 
p = 0.92 
PaO2 (mmHg)                  
 
40 
60 
285 ± 164 
166 ± 79 
408 ± 121* 
242 ± 108 
377 ± 133*  
148 ± 60 
65 (51-250) 
73 (45-102) 
PaO2 (kPa) 40 
60 
38 ± 21.9 
22.1 ± 10.5 
p = 0.08 
54.4 ± 16.1 
32.3 ± 14.4 
p = 0.008 
50.3 ± 17.7 
19.7 ± 8 
p = 0.001 
8.7 (6.8-33.3) 
9.7 (6.0-13.6) 
p = 0.40 
HCO3
- (mmol L-
1) 
40 
60 
29.5 ± 0.9 
28.7 ± 3.5 
p = 0.5 
29.4 ± 1.2 
29.5 ± 1.8 
p = 0.9 
30.9  ± 1.6 
31.0  ± 1.9 
p = 0.92 
31.4  ± 2.1 
30.5  ± 1.4 
p = 0.27 
BE (mmol/L) 40 
60 
6.1  ± 1.1 
5.5  ± 4.3 
p = 0.71 
6.2  ± 1.5 
7.1  ± 2 
p = 0.3 
7.2  ± 1.4 
8.7  ± 1.6 
p = 0.06 
8.5  ± 1.6 
7.9  ± 1.4  
p = 0.47 
* Statistical difference between the groups (p < 0.05). Blood gas analysis was 365 
performed at the onset of general anaesthesia (T0), 20-30 minutes later (T1), at the end 366 
of anaesthesia (T2) and at RSV (T3). Data are displayed as mean ± standard deviation 367 
(SD) or median (range). 368 
  369 
Figure 1. Box plot of the time taken to resume spontaneous ventilation in 18 370 
anaesthetised horses where mechanical ventilation was adjusted to maintain PE´CO2 at 371 
40 ± 5mmHg (5.3 ± 0.7 kPa) (Group40) or 60 ± 5 mmHg (8.0 ± 0.7 kPa) (Group60). 372 
 373 
